Andrea Schaffer
BSc, MSc, MBiostat, PhD
Epidemiologist
Andrea Schaffer is an epidemiologist primarily working on OpenSAFELY. Prior to coming to the University of Oxford in 2022, she was at the University of New South Wales where her research concentrated on using routinely collected data to understand how medicines are used in the population, with a particular interest in evaluating the impact of health interventions on medicine use and health outcomes. She also has expertise in interrupted time series analysis. She obtained her PhD in pharmacoepidemiology from the University of New South Wales, and also has an MSc in Epidemiology (McGill University), and an MBiostat in Biostatistics (University of Sydney).
Recent publications
-
Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP
Preprint
Andrews CD. et al, (2024)
-
OpenSAFELY: a platform for analysing electronic health records designed for reproducible research
Preprint
Nab L. et al, (2024)
-
Quality use of publicly subsidised tapentadol in Australia: a population‐based analysis
Journal article
Camacho X. et al, (2024), Internal Medicine Journal
-
Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy.
Journal article
Cohen JM. et al, (2024), Neurology, 102
-
Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform
Journal article
Ainsworth B. et al, (2023), Implementation science : IS, 18